breseq version 0.33.1 revision 8505477f25b3
mutation predictions | marginal predictions | summary statistics | genome diff | command line log |
Predicted mutations | |||||||
---|---|---|---|---|---|---|---|
evidence | seq id | position | mutation | freq | annotation | gene | description |
RA | CP000731 | 81 | N→G | 100% | intergenic (–/‑151) | – / → repA | –/replication protein A |
RA | CP000731 | 5,779 | C→T | 6.1% | intergenic (+296/‑1192) | cadX → / → USA300HOU_pUSA300HOUMR0010 | cadmium efflux regulator/MarR family transcriptional regulator |
JC | CP000731 | 6,552 | +28 bp | 100% | intergenic (+1069/‑419) | cadX → / → USA300HOU_pUSA300HOUMR0010 | cadmium efflux regulator/MarR family transcriptional regulator |
RA | CP000731 | 12,012 | A→G | 6.4% | intergenic (+175/+48) | USA300HOU_pUSA300HOUMR0014 → / ← USA300HOU_pUSA300HOUMR0015 | recombinase/hypothetical protein |
RA | CP000731 | 12,017 | C→T | 6.4% | intergenic (+180/+43) | USA300HOU_pUSA300HOUMR0014 → / ← USA300HOU_pUSA300HOUMR0015 | recombinase/hypothetical protein |
RA | CP000731 | 25,663 | Δ1 bp | 100% | coding (316/333 nt) | USA300HOU_pUSA300HOUMR0031 → | hypothetical protein |
RA | USA300TCH1516_ALE | 4,449 | C→A | 8.0% | Q171K (CAA→AAA) | recF → | DNA replication and repair protein RecF |
RA | USA300TCH1516_ALE | 9,710 | T→C | 5.2% | intergenic (+15/+72) | gyrA → / ← nnrD | DNA gyrase subunit A/ADP‑dependent (S)‑NAD(P)H‑hydrate dehydratase |
RA | USA300TCH1516_ALE | 9,716 | T→C | 5.0% | intergenic (+21/+66) | gyrA → / ← nnrD | DNA gyrase subunit A/ADP‑dependent (S)‑NAD(P)H‑hydrate dehydratase |
RA | USA300TCH1516_ALE | 9,725 | G→A | 5.5% | intergenic (+30/+57) | gyrA → / ← nnrD | DNA gyrase subunit A/ADP‑dependent (S)‑NAD(P)H‑hydrate dehydratase |
RA | USA300TCH1516_ALE | 92,987 | A→G | 6.5% | intergenic (‑72/‑65) | ricR_1 ← / → glpE | Copper‑sensing transcriptional repressor RicR/Thiosulfate sulfurtransferase GlpE |
RA | USA300TCH1516_ALE | 99,276 | G→C | 5.9% | intergenic (+70/+2) | USA300HOU_RS00465 → / ← tetA_1 | hypothetical protein/Tetracycline resistance protein, class C |
RA | USA300TCH1516_ALE | 110,651 | C→T | 12.3% | D170D (GAC→GAT) | USA300HOU_RS00515 → | putative lipoprotein |
RA | USA300TCH1516_ALE | 110,660 | T→A | 20.8% | I173I (ATT→ATA) | USA300HOU_RS00515 → | putative lipoprotein |
RA | USA300TCH1516_ALE | 111,512 | A→G | 35.5% | S194S (TCA→TCG) | USA300HOU_RS00520 → | putative lipoprotein |
RA | USA300TCH1516_ALE | 111,516 | C→A | 34.4% | Q196K (CAA→AAA) | USA300HOU_RS00520 → | putative lipoprotein |
RA | USA300TCH1516_ALE | 111,560 | T→C | 12.8% | R210R (CGT→CGC) | USA300HOU_RS00520 → | putative lipoprotein |
RA | USA300TCH1516_ALE | 111,572 | C→T | 5.7% | D214D (GAC→GAT) | USA300HOU_RS00520 → | putative lipoprotein |
RA | USA300TCH1516_ALE | 168,350 | A→T | 5.5% | intergenic (+317/+31) | yfkN_1 → / ← USA300TCH1516_00148 | Trifunctional nucleotide phosphoesterase protein YfkN/hypothetical protein |
RA | USA300TCH1516_ALE | 217,036 | T→A | 7.0% | intergenic (‑230/+23) | rocD2_1 ← / ← brnQ_1 | Ornithine aminotransferase 2/Branched‑chain amino acid transport system 2 carrier protein |
RA | USA300TCH1516_ALE | 512,004 | T→C | 5.5% | intergenic (+72/‑6691) | recR → / → speA_2 | Recombination protein RecR/Arginine decarboxylase |
RA | USA300TCH1516_ALE | 512,643 | A→G | 53.1% | intergenic (+711/‑6052) | recR → / → speA_2 | Recombination protein RecR/Arginine decarboxylase |
RA | USA300TCH1516_ALE | 614,172 | T→C | 8.5% | S828S (AGT→AGC) | sdrC → | Serine‑aspartate repeat‑containing protein C |
RA | USA300TCH1516_ALE | 614,199 | T→C | 7.3% | D837D (GAT→GAC) | sdrC → | Serine‑aspartate repeat‑containing protein C |
RA | USA300TCH1516_ALE | 618,558 | T→C | 5.6% | S1220S (AGT→AGC) | sdrD → | Serine‑aspartate repeat‑containing protein D |
RA | USA300TCH1516_ALE | 618,567 | T→C | 7.7% | D1223D (GAT→GAC) | sdrD → | Serine‑aspartate repeat‑containing protein D |
RA | USA300TCH1516_ALE | 618,588 | G→A | 7.9% | S1230S (TCG→TCA) | sdrD → | Serine‑aspartate repeat‑containing protein D |
RA | USA300TCH1516_ALE | 618,636 | G→A | 5.5% | S1246S (TCG→TCA) | sdrD → | Serine‑aspartate repeat‑containing protein D |
RA | USA300TCH1516_ALE | 622,464 | G→A | 5.4% | S1009S (TCG→TCA) | sdrE → | Serine‑aspartate repeat‑containing protein E |
RA | USA300TCH1516_ALE | 622,479 | T→C | 7.1% | D1014D (GAT→GAC) | sdrE → | Serine‑aspartate repeat‑containing protein E |
RA | USA300TCH1516_ALE | 622,533 | T→C | 7.9% | D1032D (GAT→GAC) | sdrE → | Serine‑aspartate repeat‑containing protein E |
RA | USA300TCH1516_ALE | 622,545 | T→C | 5.7% | D1036D (GAT→GAC) | sdrE → | Serine‑aspartate repeat‑containing protein E |
RA | USA300TCH1516_ALE | 622,569 | T→C | 5.7% | D1044D (GAT→GAC) | sdrE → | Serine‑aspartate repeat‑containing protein E |
RA | USA300TCH1516_ALE | 707,909 | A→T | 5.5% | M1M (TTG→ATG) † | znuC_1 ← | High‑affinity zinc uptake system ATP‑binding protein ZnuC |
RA | USA300TCH1516_ALE | 779,970 | G→A | 5.0% | intergenic (+26/+46) | csbB → / ← saeS | Putative glycosyltransferase CsbB/Histidine protein kinase SaeS |
RA | USA300TCH1516_ALE | 803,528 | C→T | 5.0% | intergenic (‑228/+42) | USA300HOU_RS03920 ← / ← dtpT | Putative lipid kinase/Di‑/tripeptide transporter |
RA | USA300TCH1516_ALE | 803,539 | A→G | 5.6% | intergenic (‑239/+31) | USA300HOU_RS03920 ← / ← dtpT | Putative lipid kinase/Di‑/tripeptide transporter |
RA | USA300TCH1516_ALE | 870,892 | G→T | 7.3% | S51R (AGC→AGA) | USA300HOU_RS04250 ← | hypothetical protein |
RA | USA300TCH1516_ALE | 937,158 | T→A | 6.6% | intergenic (+65/‑66) | USA300HOU_RS04665 → / → pepA_1 | NADH dehydrogenase‑like protein/Cytosol aminopeptidase |
RA | USA300TCH1516_ALE | 942,207 | A→G | 5.4% | intergenic (‑178/+71) | ptlE ← / ← mnhG1 | Neopentalenolactone D synthase/Na(+)/H(+) antiporter subunit G1 |
RA | USA300TCH1516_ALE | 942,210 | C→G | 5.3% | intergenic (‑181/+68) | ptlE ← / ← mnhG1 | Neopentalenolactone D synthase/Na(+)/H(+) antiporter subunit G1 |
RA | USA300TCH1516_ALE | 942,216 | T→A | 7.2% | intergenic (‑187/+62) | ptlE ← / ← mnhG1 | Neopentalenolactone D synthase/Na(+)/H(+) antiporter subunit G1 |
RA | USA300TCH1516_ALE | 942,221 | T→A | 7.2% | intergenic (‑192/+57) | ptlE ← / ← mnhG1 | Neopentalenolactone D synthase/Na(+)/H(+) antiporter subunit G1 |
RA | USA300TCH1516_ALE | 942,227 | C→G | 6.6% | intergenic (‑198/+51) | ptlE ← / ← mnhG1 | Neopentalenolactone D synthase/Na(+)/H(+) antiporter subunit G1 |
RA | USA300TCH1516_ALE | 942,230 | C→T | 6.2% | intergenic (‑201/+48) | ptlE ← / ← mnhG1 | Neopentalenolactone D synthase/Na(+)/H(+) antiporter subunit G1 |
RA | USA300TCH1516_ALE | 950,093 | T→A | 5.5% | intergenic (+87/‑275) | yugI_2 → / → USA300HOU_RS04740 | General stress protein 13/putative oxidoreductase |
RA | USA300TCH1516_ALE | 950,098 | T→A | 5.1% | intergenic (+92/‑270) | yugI_2 → / → USA300HOU_RS04740 | General stress protein 13/putative oxidoreductase |
RA | USA300TCH1516_ALE | 970,686 | T→A | 5.1% | intergenic (+32/‑297) | USA300HOU_RS04805 → / → USA300HOU_RS04810 | Ureidoglycolate lyase/hypothetical protein |
RA | USA300TCH1516_ALE | 1,042,789 | T→C | 5.6% | intergenic (+19/+70) | tagE_3 → / ← catD | Poly(glycerol‑phosphate) alpha‑glucosyltransferase/Putative oxidoreductase CatD |
RA | USA300TCH1516_ALE | 1,078,152 | A→T | 5.1% | Q510L (CAG→CTG) | purL → | Phosphoribosylformylglycinamidine synthase subunit PurL |
RA | USA300TCH1516_ALE | 1,333,796 | T→G | 9.8% | V66G (GTT→GGT) | hflX → | GTPase HflX |
RA | USA300TCH1516_ALE | 1,416,458 | A→T | 100% | I216N (ATT→AAT) | oppD_4 ← | Oligopeptide transport ATP‑binding protein OppD |
RA | USA300TCH1516_ALE | 1,513,930 | A→T | 100% | L413F (TTA→TTT) | USA300HOU_RS07375 → | hypothetical protein |
RA | USA300TCH1516_ALE | 1,584,513 | A→T | 5.5% | S400S (TCT→TCA) | USA300HOU_RS07765 ← | hypothetical protein |
RA | USA300TCH1516_ALE | 1,646,189 | G→C | 100% | A155G (GCA→GGA) | ypdF ← | Aminopeptidase YpdF |
RA | USA300TCH1516_ALE | 1,732,797 | G→A | 6.0% | E333K (GAA→AAA) | limB_2 → | Limonene 1,2‑monooxygenase |
RA | USA300TCH1516_ALE | 1,857,700 | A→G | 5.0% | I225T (ATA→ACA) | USA300HOU_RS09235 ← | hypothetical protein |
RA | USA300TCH1516_ALE | 1,857,867 | C→T | 7.2% | L169L (TTG→TTA) | USA300HOU_RS09235 ← | hypothetical protein |
RA | USA300TCH1516_ALE | 2,010,363 | C→T | 100% | C146Y (TGT→TAT) | USA300HOU_RS10125 ← | Putative multidrug export ATP‑binding/permease protein |
RA | USA300TCH1516_ALE | 2,211,248 | A→T | 8.5% | intergenic (+241/+572) | USA300HOU_RS11275 → / ← yidC | hypothetical protein/Membrane protein insertase YidC |
RA | USA300TCH1516_ALE | 2,211,658 | G→A | 5.0% | intergenic (+651/+162) | USA300HOU_RS11275 → / ← yidC | hypothetical protein/Membrane protein insertase YidC |
RA | USA300TCH1516_ALE | 2,211,670 | C→A | 5.1% | intergenic (+663/+150) | USA300HOU_RS11275 → / ← yidC | hypothetical protein/Membrane protein insertase YidC |
RA | USA300TCH1516_ALE | 2,279,705 | G→A | 100% | A943V (GCA→GTA) | ebh_3 ← | Extracellular matrix‑binding protein ebh |
RA | USA300TCH1516_ALE | 2,372,413 | C→G | 6.9% | intergenic (+164/+28) | USA300TCH1516_02262 → / ← pbuG | hypothetical protein/Guanine/hypoxanthine permease PbuG |
RA | USA300TCH1516_ALE | 2,372,419 | C→T | 6.6% | intergenic (+170/+22) | USA300TCH1516_02262 → / ← pbuG | hypothetical protein/Guanine/hypoxanthine permease PbuG |
RA | USA300TCH1516_ALE | 2,424,609 | C→T | 5.1% | intergenic (‑167/+61) | USA300HOU_RS12490 ← / ← USA300HOU_RS12495 | hypothetical protein/hypothetical protein |
RA | USA300TCH1516_ALE | 2,448,484 | A→G | 7.0% | intergenic (‑243/+34) | yxeP_4 ← / ← hutI | putative hydrolase YxeP/Imidazolonepropionase |
RA | USA300TCH1516_ALE | 2,448,493 | C→T | 8.8% | intergenic (‑252/+25) | yxeP_4 ← / ← hutI | putative hydrolase YxeP/Imidazolonepropionase |
RA | USA300TCH1516_ALE | 2,448,498 | C→T | 7.8% | intergenic (‑257/+20) | yxeP_4 ← / ← hutI | putative hydrolase YxeP/Imidazolonepropionase |
RA | USA300TCH1516_ALE | 2,468,875 | C→A | 6.9% | intergenic (‑64/‑144) | lipY ← / → USA300HOU_RS12715 | Triacylglycerol lipase/hypothetical protein |
RA | USA300TCH1516_ALE | 2,504,989 | T→C | 5.5% | intergenic (+293/+111) | USA300HOU_RS12890 → / ← gltT | hypothetical protein/Proton/sodium‑glutamate symport protein |
RA | USA300TCH1516_ALE | 2,530,791 | C→T | 5.1% | intergenic (‑42/+231) | yefM ← / ← bdbD | Antitoxin YefM/Disulfide bond formation protein D |
RA | USA300TCH1516_ALE | 2,532,298 | A→T | 100% | T15T (ACA→ACT) | femA_3 → | Aminoacyltransferase FemA |
RA | USA300TCH1516_ALE | 2,586,327 | G→T | 5.6% | I133I (ATC→ATA) | ysdC_2 ← | Putative aminopeptidase YsdC |
RA | USA300TCH1516_ALE | 2,607,228 | G→A | 6.1% | intergenic (‑25/+226) | USA300HOU_RS13430 ← / ← USA300HOU_RS13435 | hypothetical protein/putative oxidoreductase |
RA | USA300TCH1516_ALE | 2,608,820 | A→T | 5.6% | intergenic (+101/+159) | USA300TCH1516_02485 → / ← USA300HOU_RS13450 | hypothetical protein/hypothetical protein |
RA | USA300TCH1516_ALE | 2,608,825 | A→T | 10.1% | intergenic (+106/+154) | USA300TCH1516_02485 → / ← USA300HOU_RS13450 | hypothetical protein/hypothetical protein |
RA | USA300TCH1516_ALE | 2,608,829 | C→T | 7.5% | intergenic (+110/+150) | USA300TCH1516_02485 → / ← USA300HOU_RS13450 | hypothetical protein/hypothetical protein |
RA | USA300TCH1516_ALE | 2,744,213 | T→A | 5.8% | intergenic (+150/+43) | fda → / ← mqo2 | Fructose‑bisphosphate aldolase class 1/putative malate:quinone oxidoreductase 2 |
RA | USA300TCH1516_ALE | 2,774,846 | A→G | 5.5% | S780S (AGT→AGC) | clfB ← | Clumping factor B |
RA | USA300TCH1516_ALE | 2,774,855 | A→G | 6.0% | D777D (GAT→GAC) | clfB ← | Clumping factor B |
RA | USA300TCH1516_ALE | 2,774,969 | A→G | 5.9% | D739D (GAT→GAC) | clfB ← | Clumping factor B |
RA | USA300TCH1516_ALE | 2,774,975 | A→G | 6.2% | D737D (GAT→GAC) | clfB ← | Clumping factor B |
RA | USA300TCH1516_ALE | 2,775,053 | A→G | 6.5% | D711D (GAT→GAC) | clfB ← | Clumping factor B |
RA | USA300TCH1516_ALE | 2,799,069 | G→T | 8.0% | Q516K (CAA→AAA) | USA300HOU_RS14380 ← | hypothetical protein |
Unassigned new junction evidence | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
seq id | position | reads (cov) | reads (cov) | score | skew | freq | annotation | gene | product | ||
* | ? | NC_012417 | 9 = | 270 (0.030) | 9 (0.000) +AAAAAAAAAA |
6/234 | NT | 6.7% | intergenic (–/‑271) | –/USA300HOU_RS14890 | –/replication protein |
? | NC_012417 | = 3123 | 0 (0.000) | intergenic (‑449/–) | USA300HOU_RS14900/– | hypothetical protein/– | |||||
* | ? | NC_012417 | 987 = | 3578 (0.350) | 192 (0.020) | 37/232 | NT | 5.8% | pseudogene (708/709 nt) | USA300HOU_RS14890 | replication protein |
? | NC_012417 | 1013 = | 2958 (0.320) | coding (182/192 nt) | USA300HOU_RS15665 | hypothetical protein | |||||
* | ? | NC_012417 | = 1057 | 3102 (0.300) | 179 (0.020) | 36/218 | NT | 6.1% | coding (138/192 nt) | USA300HOU_RS15665 | hypothetical protein |
? | NC_012417 | = 1071 | 2889 (0.330) | coding (124/192 nt) | USA300HOU_RS15665 | hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | = 511972 | 156 (0.850) | 9 (0.050) | 6/248 | NT | 5.7% | intergenic (+40/‑6723) | recR/speA_2 | Recombination protein RecR/Arginine decarboxylase |
? | USA300TCH1516_ALE | = 512004 | 147 (0.820) | intergenic (+72/‑6691) | recR/speA_2 | Recombination protein RecR/Arginine decarboxylase | |||||
* | ? | USA300TCH1516_ALE | 512620 = | 179 (0.980) | 143 (1.140) +40 bp |
89/174 | NT | 53.8% | intergenic (+688/‑6075) | recR/speA_2 | Recombination protein RecR/Arginine decarboxylase |
? | USA300TCH1516_ALE | 1998278 = | NA (NA) | intergenic (‑6/+3329) | USA300TCH1516_01882/USA300TCH1516_01883 | tRNA‑Val/tRNA‑Ala | |||||
* | ? | USA300TCH1516_ALE | = 514652 | NA (NA) | 5 (0.030) | 4/236 | NT | NA | intergenic (+2720/‑4043) | recR/speA_2 | Recombination protein RecR/Arginine decarboxylase |
? | USA300TCH1516_ALE | = 514681 | NA (NA) | intergenic (+2749/‑4014) | recR/speA_2 | Recombination protein RecR/Arginine decarboxylase | |||||
* | ? | USA300TCH1516_ALE | = 515946 | NA (NA) | 6 (0.030) | 5/240 | NT | NA | intergenic (+4014/‑2749) | recR/speA_2 | Recombination protein RecR/Arginine decarboxylase |
? | USA300TCH1516_ALE | = 515981 | NA (NA) | intergenic (+4049/‑2714) | recR/speA_2 | Recombination protein RecR/Arginine decarboxylase | |||||
* | ? | USA300TCH1516_ALE | = 557240 | NA (NA) | 9 (0.050) | 6/246 | NT | NA | intergenic (+298/‑1471) | USA300TCH1516_00504/USA300TCH1516_00505 | tRNA‑Ala/tRNA‑Ile |
? | USA300TCH1516_ALE | = 557277 | NA (NA) | intergenic (+335/‑1434) | USA300TCH1516_00504/USA300TCH1516_00505 | tRNA‑Ala/tRNA‑Ile | |||||
* | ? | USA300TCH1516_ALE | = 760039 | 168 (0.920) | 9 (0.060) | 10/226 | NT | 5.5% | intergenic (+13/+114) | USA300HOU_RS03705/mgrA | Putative multidrug export ATP‑binding/permease protein/HTH‑type transcriptional regulator MgrA |
? | USA300TCH1516_ALE | = 760055 | 157 (0.970) | intergenic (+29/+98) | USA300HOU_RS03705/mgrA | Putative multidrug export ATP‑binding/permease protein/HTH‑type transcriptional regulator MgrA | |||||
* | ? | USA300TCH1516_ALE | 955970 = | 170 (0.930) | 10 (0.060) | 9/230 | NT | 6.4% | intergenic (‑192/+50) | glpQ_1/argH | Glycerophosphodiester phosphodiesterase/Argininosuccinate lyase |
? | USA300TCH1516_ALE | 956005 = | 139 (0.840) | intergenic (‑227/+15) | glpQ_1/argH | Glycerophosphodiester phosphodiesterase/Argininosuccinate lyase | |||||
* | ? | USA300TCH1516_ALE | 1026972 = | 183 (1.000) | 9 (0.050) | 7/242 | NT | 5.1% | intergenic (+13/‑221) | USA300HOU_RS05060/USA300HOU_RS05065 | hypothetical protein/Serine protease HtrA‑like protein |
? | USA300TCH1516_ALE | 1027002 = | 162 (0.930) | intergenic (+43/‑191) | USA300HOU_RS05060/USA300HOU_RS05065 | hypothetical protein/Serine protease HtrA‑like protein | |||||
* | ? | USA300TCH1516_ALE | = 1265511 | 122 (0.670) | 9 (0.060) | 9/224 | NT | 7.3% | intergenic (+19/‑154) | femA_1/dprA | Aminoacyltransferase FemA/DNA processing protein DprA |
? | USA300TCH1516_ALE | = 1265527 | 120 (0.740) | intergenic (+35/‑138) | femA_1/dprA | Aminoacyltransferase FemA/DNA processing protein DprA | |||||
* | ? | USA300TCH1516_ALE | 1456948 = | 174 (0.950) | 17 (0.100) +GTTTT |
4/244 | NT | 8.7% | intergenic (‑62/‑182) | USA300HOU_RS07230/USA300HOU_RS07235 | hypothetical protein/hypothetical protein |
? | USA300TCH1516_ALE | = 1918540 | 199 (1.090) | intergenic (‑258/+240) | USA300HOU_RS07235/USA300HOU_RS09510 | hypothetical protein/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | 1525192 = | 148 (0.810) | 7 (0.040) | 7/232 | NT | 5.0% | intergenic (‑265/+57) | asnS/dinG_1 | Asparagine‑‑tRNA ligase/putative ATP‑dependent helicase DinG |
? | USA300TCH1516_ALE | 1525239 = | 130 (0.780) | intergenic (‑312/+10) | asnS/dinG_1 | Asparagine‑‑tRNA ligase/putative ATP‑dependent helicase DinG | |||||
* | ? | USA300TCH1516_ALE | 1533866 = | 173 (0.950) | 9 (0.050) | 9/232 | NT | 5.7% | coding (219/588 nt) | USA300HOU_RS07480 | hypothetical protein |
? | USA300TCH1516_ALE | 1533900 = | 138 (0.830) | coding (185/588 nt) | USA300HOU_RS07480 | hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | 1732959 = | 174 (0.950) | 10 (0.060) | 6/230 | NT | 6.7% | intergenic (+145/+92) | limB_2/USA300HOU_RS08645 | Limonene 1,2‑monooxygenase/hypothetical protein |
? | USA300TCH1516_ALE | 1733016 = | 123 (0.740) | intergenic (+202/+35) | limB_2/USA300HOU_RS08645 | Limonene 1,2‑monooxygenase/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | = 2057387 | 137 (0.750) | 7 (0.040) | 4/232 | NT | 5.2% | intergenic (+144/+148) | USA300HOU_RS10370/USA300HOU_RS10375 | hypothetical protein/hypothetical protein |
? | USA300TCH1516_ALE | = 2057403 | 132 (0.790) | intergenic (+160/+132) | USA300HOU_RS10370/USA300HOU_RS10375 | hypothetical protein/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | = 2062972 | 139 (0.760) | 17 (0.100) | 10/226 | NT | 12.2% | intergenic (+53/+137) | pheA/sdcS | P‑protein/Sodium‑dependent dicarboxylate transporter SdcS |
? | USA300TCH1516_ALE | = 2062986 | 122 (0.750) | intergenic (+67/+123) | pheA/sdcS | P‑protein/Sodium‑dependent dicarboxylate transporter SdcS | |||||
* | ? | USA300TCH1516_ALE | 2082639 = | 149 (0.820) | 8 (0.050) | 8/242 | NT | 5.5% | intergenic (+280/+44) | aspC/USA300HOU_RS10520 | Aspartate aminotransferase/65 kDa membrane protein |
? | USA300TCH1516_ALE | 2082667 = | 135 (0.780) | intergenic (+308/+16) | aspC/USA300HOU_RS10520 | Aspartate aminotransferase/65 kDa membrane protein | |||||
* | ? | USA300TCH1516_ALE | 2256396 = | 176 (0.960) | 15 (0.090) | 11/226 | NT | 9.6% | intergenic (+49/+72) | deoD1/dps | Purine nucleoside phosphorylase DeoD‑type 1/General stress protein 20U |
? | USA300TCH1516_ALE | 2256443 = | 125 (0.770) | intergenic (+96/+25) | deoD1/dps | Purine nucleoside phosphorylase DeoD‑type 1/General stress protein 20U | |||||
* | ? | USA300TCH1516_ALE | 2508438 = | 233 (1.280) | 11 (0.070) | 8/232 | NT | 5.4% | intergenic (+26/+81) | USA300TCH1516_02393/narT | Acid shock protein/putative nitrate transporter NarT |
? | USA300TCH1516_ALE | 2508486 = | 174 (1.040) | intergenic (+74/+33) | USA300TCH1516_02393/narT | Acid shock protein/putative nitrate transporter NarT | |||||
* | ? | USA300TCH1516_ALE | 2716742 = | 154 (0.840) | 12 (0.070) | 11/232 | NT | 7.2% | intergenic (+50/+100) | USA300HOU_RS13965/USA300HOU_RS13970 | hypothetical protein/hypothetical protein |
? | USA300TCH1516_ALE | 2716816 = | 168 (1.010) | intergenic (+124/+26) | USA300HOU_RS13965/USA300HOU_RS13970 | hypothetical protein/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | = 2716752 | 154 (0.840) | 9 (0.050) | 7/232 | NT | 5.5% | intergenic (+60/+90) | USA300HOU_RS13965/USA300HOU_RS13970 | hypothetical protein/hypothetical protein |
? | USA300TCH1516_ALE | = 2716804 | 168 (1.010) | intergenic (+112/+38) | USA300HOU_RS13965/USA300HOU_RS13970 | hypothetical protein/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | = 2872577 | 193 (1.060) | 15 (0.090) | 12/232 | NT | 7.5% | intergenic (‑113/+14) | rnpA/rpmH | Ribonuclease P protein component/50S ribosomal protein L34 |
? | USA300TCH1516_ALE | = 2872581 | 193 (1.160) | intergenic (‑117/+10) | rnpA/rpmH | Ribonuclease P protein component/50S ribosomal protein L34 |